Literature DB >> 6093722

High-dose ketoconazole therapy and adrenal and testicular function in humans.

A Pont, J R Graybill, P C Craven, J N Galgiani, W E Dismukes, R E Reitz, D A Stevens.   

Abstract

Ketoconazole, an oral antifungal, when given in conventional doses, transiently blocks testosterone synthesis and adrenal response to corticotropin. Higher therapeutic doses (ie, 800 to 1,200 mg/day), even once daily, caused more prolonged blockade. In some men, the serum testosterone concentrations were always subnormal. Bound and free testosterone values were equally diminished. Oligospermia and azospermia after prolonged therapy were noted. Impotence and decreased libido were found. Gynecomastia appeared more common than with lower doses. Depressed response to corticotropin was pronounced. Urine cortisol excretion was depressed. The blockade appeared related to the serum ketoconazole concentration. Instances of normal hormone levels or responsiveness were associated with low ketoconazole concentrations. The hormonal effects were generally unrelated to duration of therapy, although there may have been partial reversal with continued therapy. These effects appeared reversible with discontinuation of therapy. Patients receiving ketoconazole should be considered potentially unable to mount an adrenal stress response and may require testosterone supplementation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093722

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  38 in total

Review 1.  Antifungal therapy: from amphotericin B to present.

Authors:  W E Dismukes
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

Review 2.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

3.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males.

Authors:  N M Waite; D J Edwards; W S Arnott; L H Warbasse
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Adrenal function in paracoccidioidomycosis: a prospective study in patients before and after ketoconazole therapy.

Authors:  A Abad; I Gomez; P Velez; A Restrepo
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

6.  Preoperative ketoconazole therapy for adrenocortical carcinoma.

Authors:  L J Sinnaeve; G P Becks
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

7.  Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.

Authors:  Megan McGrath; Celena Ma; Douglas E Raines
Journal:  J Pharmacol Exp Ther       Date:  2017-12-04       Impact factor: 4.030

Review 8.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

9.  Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.

Authors:  M A Fisher; P G Lee; W F Tarry
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

10.  Cytotoxicity of ketoconazole in malignant cell lines.

Authors:  C F Rochlitz; L E Damon; M B Russi; A Geddes; E C Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.